Systemic and Mucosal Immune Responses to Sublingual or Intramuscular Human Papilloma Virus Antigens in Healthy Female Volunteers

Sublingual vaccination

(2011) Cecil Czerkinsky et al.   Human vaccines & immunotherapeutics

Adjuvants and Vector Systems for Allergy Vaccines

(2011) Philippe Moingeon et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Phase I Randomised Clinical Trial of an HIV-1CN54, Clade C, Trimeric Envelope Vaccine Candidate Delivered Vaginally

(2011) David J. Lewis et al.   PLoS One

Prevalence of Human Papillomavirus Antibodies in Males and Females in England

(2011) Sarika Desai et al.   SEXUALLY TRANSMITTED DISEASES

Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera

(2011) Eve Draper et al.   VACCINE

The first international standard for antibodies to HPV 16

(2011) Morag Ferguson et al.   VACCINE

Vaccines to Prevent Infections by Oncoviruses

(2010) John T. Schiller et al.   Annual Review of Microbiology

Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics

(2010) T. C. Pomfret et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Enhanced humoral and cellular immune responses after sublingual immunization against human papillomavirus 16 L1 protein with adjuvants

(2010) Hee-Jeong Cho et al.   VACCINE

Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract

(2010) Catherine Hervouet et al.   VACCINE

A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

(2009) S. K. Kjaer et al.   Cancer Prevention Research

Sublingual Immunization with Nonreplicating Antigens Induces Antibody-Forming Cells and Cytotoxic T Cells in the Female Genital Tract Mucosa and Protects against Genital Papillomavirus Infection

(2009) N. Cuburu et al.   JOURNAL OF IMMUNOLOGY

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

(2009) Darron R. Brown et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET

Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin

(2009) David J. M. Lewis et al.   PLoS One

Sublingual vaccination with influenza virus protects mice against lethal viral infection

(2008) J.-H. Song et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA